Search research articles
Contact Us
Filters
Showing results (201-210 of 645) with videos related to
Page
of 65
Sort By:
Biochemistry
|
April 4, 1989
Homocitrate is a component of the iron-molybdenum cofactor of nitrogenase
T R Hoover, J Imperial, P W Ludden, et al.
European Journal of Gynaecological Oncology
|
January 1, 1988
Risk factors in ovarian cancer
L McGowan, H J Norris, P Hartge, et al.
Science (New York, N.Y.)
|
September 29, 1975
Cancer by county: new resource for etiologic clues
R Hoover, T J Mason, F W McKay, et al.
Plos Pathogens
|
February 2, 2026
Correction: A Helicobacter pylori flagellar motor accessory is needed to maintain the barrier function of the outer membrane during flagellar rotation
Kyle Rosinke, Shoichi Tachiyama, Jan Mrázek, et al.
The Journal of Biological Chemistry
|
August 12, 1994
Constitutive ATP hydrolysis and transcription activation by a stable, truncated form of Rhizobium meliloti DCTD, a sigma 54-dependent transcriptional activator
J H Lee, D Scholl, B T Nixon, et al.
Journal of Bacteriology
|
July 3, 2004
Helicobacter pylori FlgR is an enhancer-independent activator of sigma54-RNA polymerase holoenzyme
Priyanka Brahmachary, Mona G Dashti, Jonathan W Olson, et al.
The Journal of Infectious Diseases
|
February 1, 1996
Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men
J B Margolick, H Farzadegan, D R Hoover, et al.
The New England Journal of Medicine
|
August 3, 1989
The risk of breast cancer after estrogen and estrogen-progestin replacement
L Bergkvist, H O Adami, I Persson, et al.
Molecular Microbiology
|
February 12, 1998
A conserved region in the sigma54-dependent activator DctD is involved in both binding to RNA polymerase and coupling ATP hydrolysis to activation
Y K Wang, J H Lee, J M Brewer, et al.
Cardiovascular Drugs and Therapy
|
October 1, 1995
Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs
A S Dobs, M Prasad, A Goldberg, et al.
Page
of 65
Search research articles
Search
Showing results (201-210 of 645) with videos related to
Sort By:
Page
of 65
Biochemistry
|
April 4, 1989
Homocitrate is a component of the iron-molybdenum cofactor of nitrogenase
T R Hoover, J Imperial, P W Ludden, et al.
European Journal of Gynaecological Oncology
|
January 1, 1988
Risk factors in ovarian cancer
L McGowan, H J Norris, P Hartge, et al.
Science (New York, N.Y.)
|
September 29, 1975
Cancer by county: new resource for etiologic clues
R Hoover, T J Mason, F W McKay, et al.
Plos Pathogens
|
February 2, 2026
Correction: A Helicobacter pylori flagellar motor accessory is needed to maintain the barrier function of the outer membrane during flagellar rotation
Kyle Rosinke, Shoichi Tachiyama, Jan Mrázek, et al.
The Journal of Biological Chemistry
|
August 12, 1994
Constitutive ATP hydrolysis and transcription activation by a stable, truncated form of Rhizobium meliloti DCTD, a sigma 54-dependent transcriptional activator
J H Lee, D Scholl, B T Nixon, et al.
Journal of Bacteriology
|
July 3, 2004
Helicobacter pylori FlgR is an enhancer-independent activator of sigma54-RNA polymerase holoenzyme
Priyanka Brahmachary, Mona G Dashti, Jonathan W Olson, et al.
The Journal of Infectious Diseases
|
February 1, 1996
Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men
J B Margolick, H Farzadegan, D R Hoover, et al.
The New England Journal of Medicine
|
August 3, 1989
The risk of breast cancer after estrogen and estrogen-progestin replacement
L Bergkvist, H O Adami, I Persson, et al.
Molecular Microbiology
|
February 12, 1998
A conserved region in the sigma54-dependent activator DctD is involved in both binding to RNA polymerase and coupling ATP hydrolysis to activation
Y K Wang, J H Lee, J M Brewer, et al.
Cardiovascular Drugs and Therapy
|
October 1, 1995
Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs
A S Dobs, M Prasad, A Goldberg, et al.
Page
of 65